Cuprous ion doped porous titanium dioxide sound-sensitive agent as well as preparation method and application thereof
By doping copper ions in porous titanium dioxide sound-sensitizer and using ultrasonic induction methods, the problem of uncontrollable copper ion carrier release is solved, the controllability and efficiency of copper death treatment is achieved, and the inhibition of tumor cells is enhanced. Effect.
Patent Information
- Application Number
- CN202411004147.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-22
AI Technical Summary
Existing copper ion carriers have time-dependent and uncontrollable release behavior in tumor treatment, resulting in poor copper death and may produce nonselective toxicity to normal cells.
Design a porous titanium dioxide sonic sensitizer with monovalent copper ion doping, doping copper ions by hydrothermal method and modifying polyvinylpyrrolelenone on the surface, using ultrasound to induce the controlled release of copper ions, combined with acoustic dynamics therapy to improve Treatment effect.
The controlled release of copper ions is achieved, the inhibitory effect on tumor cells is enhanced, the damage to normal tissue is reduced, the production efficiency of singlet oxygen is improved, and the effect of copper death treatment is synergistically improved.
Smart Images

Figure CN118987204A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of nanomaterials, and in particular to a porous titanium dioxide sonosensitizer doped with monovalent copper ions and a preparation method and application thereof. Background Art
[0002] Copper death is a programmed cell death mode associated with copper. Unlike apoptosis, pyroptosis, necrosis and ferroptosis, copper death occurs through the accumulation of intracellular copper ions, leading to the aggregation of lipoylated proteins, the downregulation of iron-sulfur cluster proteins and ultimately affecting the mitochondrial tricarboxylic acid (TCA) cycle. Copper death provides a new perspective for tumor therapy. However, the existence of copper ion efflux channels will pump excess copper ions out of cells, resulting in the difficulty of endogenous copper ion levels to meet the demand for copper reduction. In order to maintain a higher copper ion concentration in cells and induce copper death, ion carriers have been developed. Unfortunately, it may lead to increased cytotoxicity with non-selective accumulation. Recently, nanomaterials have passive targeting capabilities with enhanced permeability and retention (EPR) effects. Copper-based nanocarriers have been developed to deal with the tumor microenvironment. However, the release behavior of copper ions is time-dependent and uncontrollable. Therefore, it is necessary to develop a copper ion release method with spatiotemporal controllability to make it more suitable for copper death.
[0003] Sonodynamic therapy (SDT) is a non-invasive treatment modality that has attracted widespread attention because its tissue penetration depth is much higher than that of light-based tumor treatment modalities. SDT induces sonosensitizers to generate singlet oxygen ( 1 Under the action of ultrasound, the electrons of the semiconductor sonosensitizer are transferred from the valence band (VB) to the conduction band (CB), thereby generating active hole-electron (h + -e - ), which promoted 1 The formation of O2. However, h + -e - The compound will reduce the generation 1 O2 efficiency. To alleviate h + -e - A series of measures have been developed, including the composite of copper ions, the introduction of precious metal nanoparticles, the use of hole traps, and the adjustment of band gaps. It is worth noting that high levels of GSH in tumor cells can act as endogenous hole traps, and the doping of the metal element copper can also reduce the band gap. Designing and constructing copper ion-doped sonosensitizers is expected to achieve controllable release of copper ions and maximize the inhibitory effect of copper death on tumor cells. It provides new principles and methods for the design of the next generation of anti-tumor drugs. Summary of the invention
[0004] In order to solve the above technical problems, nanomedicines with ultrasound responsiveness are designed and developed to break the current bottleneck of copper death in tumor treatment:
[0005] The present application provides a sonosensitizer doped with monovalent copper ions, wherein the sonosensitizer is based on porous titanium dioxide nanoparticles, and monovalent copper ions are doped into the porous titanium dioxide nanoparticle structure by a hydrothermal method, wherein the surface of the porous titanium dioxide nanoparticles doped with monovalent copper ions of the sonosensitizer is modified with polyvinyl pyrrolidone.
[0006] The present application also provides a method for preparing a monovalent copper ion-doped sonosensitizer, comprising the following steps:
[0007] Step 1: preparing porous titanium dioxide nanoparticles: preparing a surfactant template solution, using the surfactant template solution, ethanol and an alkaline solution to prepare an alkaline growth solution, using titanate as a raw material, and dropping a titanium dioxide precursor solution into the alkaline growth solution to prepare porous titanium dioxide nanoparticles as a substrate for the sonosensitizer;
[0008] Step 2: preparing porous titanium dioxide nanoparticles doped with monovalent copper ions: preparing an aqueous solution containing copper chloride, dispersing the porous titanium dioxide nanoparticles prepared in step 1 into an ethanol solution, adding the aqueous solution containing copper chloride to the ethanol solution containing porous titanium dioxide nanoparticles, ultrasonically dispersing uniformly to obtain a mixed solution, transferring the mixed solution to a hydrothermal reactor, and after high-temperature treatment, centrifuging the mixed solution, and washing with ethanol and water to obtain porous titanium dioxide nanoparticles doped with monovalent copper ions;
[0009] Step 3: Preparation of monovalent copper ion-doped sonosensitizer: PVP is dispersed in water to obtain a solution containing PVP, and the porous titanium dioxide nanoparticles doped with monovalent copper ions obtained in step 2 are dispersed in the aqueous solution of PVP. After stirring overnight, the porous titanium dioxide nanoparticles doped with monovalent copper ions modified by PVP are obtained by centrifugation to obtain a monovalent copper ion-doped sonosensitizer.
[0010] The present application also provides the use of a monovalent copper ion-doped sonosensitizer in the preparation of an anti-tumor drug.
[0011] Beneficial Effects
[0012] Mesoporous titanium dioxide is an inorganic sonosensitizer with good biocompatibility. Doping copper ions into the titanium dioxide structure can not only reduce the band gap of the sonosensitizer and improve the sonosensitivity effect, but also control the release of copper ions through ultrasonic stimulation.
[0013] Compared with Cu(ⅠⅠ), Cu(Ⅰ) is more cytotoxic because it can directly bind to acylated TCA proteins. In addition, downregulation of GSH can also enhance copper death. Based on the advantages of copper death effect in tumor treatment, in order to achieve controllable and enhanced copper death therapeutic effect, a monovalent copper ion-doped porous titanium dioxide (p-TiO2-Cu(Ⅰ)) nanosonosensitizer was designed, and polyvinyl pyrrolidone (PVP) was modified on its surface to improve its biocompatibility and stability.
[0014] This copper-doped mesoporous TiO2 can maintain its structural integrity in the blood circulation at neutral pH. However, when it enters the weakly acidic tumor tissue, it can precisely control the exogenous US (ultrasound) stimulation to trigger the sonodynamic properties of p-TiO2-Cu(Ⅰ), generate ROS, and induce the degradation of p-TiO2-Cu(Ⅰ), releasing Cu at the tumor site. + , thereby minimizing damage to normal tissue.
[0015] The drug was passively targeted and enriched in the tumor site. Under ultrasound induction, p-TiO2-Cu(Ⅰ) showed better sonodynamic effect than p-TiO2 and rapidly released Cu(Ⅰ), which caused cell death by inducing mitochondrial proteotoxic stress. - With h + Respectively react with oxygen and GSH in tumor cells, h + -e - The compound has been alleviated and improved 1 The efficiency of O2 generation consumes GSH, which enhances the effects of SDT and copper death therapy at the same time. This synergistic treatment mode not only shows excellent tumor inhibition, but also provides a new paradigm for achieving efficient copper death therapy. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 The transmission electron microscope characterization of the solid TiO2 morphology structure in one embodiment of the present application is shown;
[0017] Figure 2 Transmission electron microscopy characterization of the porous p-TiO2-Cu(Ⅰ) morphology structure in one embodiment of the present application is shown;
[0018] Figure 3 The high-angle annular dark field scanning transmission electron microscopy characterization of p-TiO2-Cu(Ⅰ) and the distribution analysis results of three elements of titanium (Ti), copper (Cu) and oxygen (O) are shown in one embodiment of the present application;
[0019] Figure 4 The X-ray photoelectron spectrum detection results of porous p-TiO2-Cu(Ⅰ) in one embodiment of the present application are shown;
[0020] Figure 5 The acoustic sensing performance results of porous p-TiO2-Cu(Ⅰ) in one embodiment of the present application are shown;
[0021] Figure 6 The band gap detection result of porous p-TiO2-Cu(Ⅰ) in one embodiment of the present application is shown;
[0022] Figure 7 The copper ion release rate of p-TiO2-Cu(I) under ultrasound was measured by inductively coupled plasma optical emission spectroscopy (ICP-OES) in one embodiment of the present application, wherein (A) is without US stimulation, and (B) is with US stimulation.
[0023] (C) is higher than that without US stimulation under the same pH conditions;
[0024] Figure 8 The cell viability graphs of PANC-1 cells after being treated in different ways in one embodiment of the present application are shown, wherein (A) is the cytotoxicity results of the sonosensitizer p-TiO2-Cu(Ⅰ) without ultrasound and with ultrasound treatment, and (B) is the cytotoxicity results of PBS, p-TiO2, and p-TiO2-Cu(Ⅰ) without ultrasound and with ultrasound treatment, respectively. DETAILED DESCRIPTION
[0025] The preferred embodiments of the present invention will be described in detail below in conjunction with examples. It should be understood that the following examples are provided only for the purpose of illustration and are not intended to limit the scope of the present invention. Those skilled in the art may make various modifications and substitutions to the present invention without departing from the purpose and spirit of the present invention.
[0026] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.
[0027] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0028] An embodiment of the present application provides a sonosensitizer doped with monovalent copper ions, wherein the sonosensitizer is based on porous titanium dioxide nanoparticles, and monovalent copper ions are doped into the porous titanium dioxide nanoparticles by a hydrothermal method, wherein the surface of the porous titanium dioxide nanoparticles doped with monovalent copper ions is modified with polyvinyl pyrrolidone.
[0029] An embodiment of the present application provides a method for preparing a monovalent copper ion-doped sonosensitizer, comprising the following steps:
[0030] Step 1: preparing porous titanium dioxide nanoparticles: preparing a surfactant template solution, using the surfactant template solution, ethanol and an alkaline solution to prepare an alkaline growth solution, using titanate as a raw material, and dropping a titanium dioxide precursor solution into the alkaline growth solution to prepare porous titanium dioxide nanoparticles as a substrate for the sonosensitizer;
[0031] Step 2: preparing porous titanium dioxide nanoparticles doped with monovalent copper ions: preparing an aqueous solution containing copper chloride, dispersing the porous titanium dioxide nanoparticles prepared in step 1 into an ethanol solution, adding the aqueous solution containing copper chloride to the ethanol solution containing porous titanium dioxide nanoparticles, ultrasonically dispersing uniformly to obtain a mixed solution, transferring the mixed solution to a hydrothermal reactor, and after high-temperature treatment, centrifuging the mixed solution, and washing with ethanol and water to obtain porous titanium dioxide nanoparticles doped with monovalent copper ions;
[0032] Step 3: Preparation of monovalent copper ion-doped sonosensitizer: PVP is dispersed in water to obtain a solution containing PVP, and the porous titanium dioxide nanoparticles doped with monovalent copper ions obtained in step 2 are dispersed in the aqueous solution of PVP. After stirring overnight, the porous titanium dioxide nanoparticles doped with monovalent copper ions modified by PVP are obtained by centrifugation to obtain a monovalent copper ion-doped sonosensitizer.
[0033] In one embodiment, the preparation of the surfactant template solution is to disperse hexadecylamine in an ethanol solution.
[0034] In one embodiment, the alkaline growth liquid is a mixture of ethanol and ammonia water.
[0035] In one embodiment, the titanium dioxide precursor is isopropyl titanate.
[0036] In one embodiment, a titanium dioxide precursor solution is added dropwise to the alkaline growth solution, and the mixed solution is stirred for 1.5 hours to grow titanium dioxide nanoparticles.
[0037] In one embodiment, in the step 2, the titanium dioxide nanoparticles prepared in the step 1 are dispersed in an ethanol solution. In order to disperse the titanium dioxide nanoparticles in an ethanol solution of equal volume, a hydrothermal method is used to remove the surfactant hexadecylamine, and simultaneously achieve doping and reduction of copper ions; wherein the temperature of the hydrothermal method is 150-200°C, and the hydrothermal reaction time is 1-12 hours.
[0038] One embodiment of the present application provides the use of a sonosensitizer doped with monovalent copper ions in the preparation of an anti-tumor drug.
[0039] In one embodiment, the concentration range of the sonosensitizer is 0-80 ug / mL.
[0040] In one embodiment, the sonosensitizer is sonicated using an ultrasound therapy device.
[0041] In one embodiment, the fresh culture medium containing the sonosensitizer is incubated with the tumor cells for 5 hours, and the cells are sonicated using an ultrasound therapy device (1 MHz, 1 W / cm 2 ), and then incubated for 19 hours after 15 minutes; after the incubation, the cells were washed with PBS for 3 times, and the cell activity was determined by MTT colorimetry to obtain the inhibitory effect of monovalent copper ion-doped porous titanium dioxide sonosensitizer on tumor cell proliferation.
[0042] Preparation of nanocarriers:
[0043] 1. Preparation of titanium dioxide nanoparticles (TiO2)
[0044] 0.4 g of hexadecylamine was dissolved in 49 mL of ethanol solution, and 1 mL of ammonia water was added thereto. The mixture was stirred for 10 minutes, and then 0.6 mL of isopropyl titanate was added dropwise to the solution. The reaction was stirred for 1.5 hours to obtain white titanium dioxide nanoparticles.
[0045] 2. Preparation of monovalent copper ion-doped porous titanium dioxide nanoparticles (p-TiO2-Cu(Ⅰ))
[0046] 10 mg of solid TiO2 was dispersed in an ethanol solution, and then an equal volume of water and 100 uL of copper chloride solution (0.1 M) were added. After stirring evenly, the reactants were transferred to a hydrothermal reactor and heated at 180 ° C for 3 hours. After the solution was cooled to room temperature, it was washed three times with pure water to obtain monovalent copper ion-doped titanium dioxide nanoparticles.
[0047] 3. Preparation of PVP-modified monovalent copper ion-doped porous titanium dioxide sonosensitizer
[0048] The ligand-free porous p-TiO2-Cu(Ⅰ) was dispersed in 10 mL of deionized water containing 1 gram of PVP. After stirring overnight, the mixture was centrifuged to obtain a PVP-modified monovalent copper ion-doped porous titanium dioxide sonosensitizer.
[0049] Characterization of Nanocarriers:
[0050] 1. Characterization test of porous p-TiO2-Cu(Ⅰ)
[0051] TEM images show that solid TiO2 is etched to form a porous structure after the surfactant is removed by high-temperature hydrothermal method. In addition, TiO2 is also porous after copper doping ( Figure 1 and 2), the morphology remains uniform. To confirm whether Cu is doped into the TiO2 structure, the synthesized p-TiO2-Cu(Ⅰ) was characterized using HAADF-STEM element mapping images, such as Figure 3 As shown, element mapping shows that the material is composed of three elements: Cu, O, and Ti, confirming that Cu is indeed doped into the TiO2 structure. Further analysis of the size of p-TiO2-Cu(Ⅰ) showed that its size was about 174nm. In order to further characterize the valence state of Cu ions, XPS was used to analyze the chemical composition of p-TiO2-Cu(Ⅰ), and Cu 2p was analyzed. The two main peaks at 931.3eV and 951.1eV corresponded to Cu 2p3 / 2 and Cu 2p1 / 2( Figure 4 ), indicating that Cu element is doped into the TiO2 skeleton in the form of Cu(Ⅰ).
[0052] 2. Characterization and testing of porous p-TiO2-Cu(Ⅰ)
[0053] The generation of p-TiO2-Cu(Ⅰ) under US stimulation was investigated in vitro. 1 In order to evaluate the sonodynamic performance of p-TiO2-Cu(Ⅰ), DPBF was used to detect the generation of O2 by US-triggered p-TiO2 and p-TiO2-Cu(Ⅰ). 1 O2. 1 O2 can react with DPBF, reducing its absorbance at 416nm. Figure 5 As shown in the figure, both p-TiO2 and p-TiO2-Cu(Ⅰ) can reduce the absorbance of DPBF, and the reduction of p-TiO2-Cu(Ⅰ) is more obvious. This shows that both p-TiO2 and p-TiO2-Cu(Ⅰ) have sonodynamic properties and can generate 1 After doping with copper, the sonodynamic efficiency of TiO2-Cu(Ⅰ) is stronger than that of p-TiO2. In addition, after adding GSH, the sonodynamic efficiency of p-TiO2-Cu(Ⅰ) is further improved, because GSH can react with the h generated by TiO2-Cu(Ⅰ) under US stimulation. + reaction, which alleviates the h + -e - The compound improves 1 The generation efficiency of O2. p-TiO2 and p-TiO2-Cu(Ⅰ) were characterized by UV-visible spectroscopy, such as Figure 6 As shown in the figure, the band gap of TiO2 is 3.12eV, while the band gap of TiO2-Cu(Ⅰ) is 3.02eV. This shows that Cu doping makes the band gap of TiO2 smaller, and under the same US stimulation, e is more likely to occur. - With h+ separation, producing sonodynamic effect.
[0054] 3. Effects of ultrasound and pH on copper ion release performance
[0055] The effects of pH and US stimulation on the Cu(Ⅰ) release behavior of p-TiO2-Cu(Ⅰ) in PBS solution were further evaluated by ICP-OES. Figure 7 As shown in Figure A, without US stimulation, the cumulative release of p-TiO2-Cu(Ⅰ) in pH 7.4 PBS buffer solution was small over 24 hours, while in pH 5.5 acidic buffer solution, it was rapidly released within 1 hour and reached nearly 80% at 24 hours. Under US stimulation, Cu(Ⅰ) was rapidly released within 15 minutes ( Figure 7 In the PBS buffer solution of pH 5.5, more than 80% of Cu(Ⅰ) was released after 15 minutes of US stimulation, which was higher than the cumulative release in 24 hours without US stimulation under the same pH conditions ( Figure 7 Therefore, this copper-doped mesoporous TiO2 can maintain its structural integrity in the blood circulation at neutral pH, but when it enters the weakly acidic tumor tissue, it can precisely control the exogenous US stimulation to trigger the sonodynamic properties of p-TiO2-Cu(Ⅰ), generate ROS, and induce the degradation of p-TiO2-Cu(Ⅰ), releasing Cu(Ⅰ) at the tumor site, thereby minimizing damage to normal tissues.
[0056] Application of Nanocarriers:
[0057] PANC-1 cells were digested and inoculated into 96-well plates, with approximately 10 cells per well. 4 After 24 hours of incubation in the incubator, the culture medium was removed and replaced with fresh culture medium containing different concentrations of p-TiO2-Cu(Ⅰ) (0, 10, 20, 40, 80 μg / mL) for 24 hours. In order to evaluate the effect of ultrasound on the therapeutic effect, the cells incubated for 5 hours with different concentrations of p-TiO2-Cu(Ⅰ) were irradiated with US (1 MHz, 1 W / cm 2 ) After irradiation for 15 minutes, continue incubation for 19 hours. After the incubation, discard the culture solution, wash with PBS 3 times, add 100 μL MTT solution to each well, incubate in the incubator for 4 hours, discard the upper solution, add 100 μL DMSO to each well, and shake for half an hour. The absorbance value of each well at 490nm was recorded by an ELISA instrument to calculate the cell activity of each group.
[0058] The cytotoxicity of p-TiO2-Cu(Ⅰ) and the therapeutic effects of different concentrations of p-TiO2-Cu(Ⅰ) under US stimulation were analyzed by MTT assay. Figure 8As shown in Figure A, with the increase of p-TiO2-Cu(Ⅰ) concentration, the activity of PANC-1 cells decreased slightly, but even when the p-TiO2-Cu(Ⅰ) concentration was as high as 80μg / mL, the activity of the cells remained above 80%, indicating that p-TiO2-Cu(Ⅰ) was not highly toxic to cells without US stimulation. However, under the same experimental conditions, after US stimulation, the activity of the cells dropped sharply, and the lethality rate reached 70%. US itself is not harmful to cells ( Figure 8 In addition, under US stimulation, the toxicity of p-TiO2-Cu(Ⅰ) at the same concentration is much higher than that of TiO2. This also confirms that US not only stimulates the sonodynamic effect of TiO2 to produce ROS, but also promotes the release of Cu(Ⅰ), thereby improving the therapeutic effect through the synergy of SDT and copper death treatment.
[0059] The present application example uses porous titanium dioxide as a template, and prepares a porous titanium dioxide nanosonosensitizer doped with monovalent copper ions by ion doping and in-situ reduction. The deep penetration property of ultrasound is used to stimulate the sonosensitivity of titanium dioxide, realize the sonodynamic therapy process, and lead to cell apoptosis; on the other hand, ultrasound can realize the controlled release of monovalent copper ions in the sonosensitizer. The released monovalent copper ions oligomerize with mitochondrial proteins in the tricarboxylic acid cycle, inducing copper death of tumor cells.
[0060] The above are only preferred embodiments of the present invention. It should be pointed out that, for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the protection scope of the present invention.
Claims
1. A monovalent copper ion-doped sonosensitizer, characterized in that: The sonosensitizer is based on porous titanium dioxide nanoparticles, and monovalent copper ions are doped into the porous titanium dioxide nanoparticles through a hydrothermal method, wherein the surface of the porous titanium dioxide nanoparticles doped with monovalent copper ions is modified with polyvinyl pyrrolidone.
2. The method for preparing the monovalent copper ion-doped sonosensitizer according to claim 1, characterized in that: The following steps are involved: Step 1: preparing porous titanium dioxide nanoparticles: preparing a surfactant template solution, using the surfactant template solution, ethanol and an alkaline solution to prepare an alkaline growth solution, using titanate as a raw material, and dropping a titanium dioxide precursor solution into the alkaline growth solution to prepare porous titanium dioxide nanoparticles as a substrate for the sonosensitizer; Step 2: preparing porous titanium dioxide nanoparticles doped with monovalent copper ions: preparing an aqueous solution containing copper chloride, dispersing the porous titanium dioxide nanoparticles prepared in step 1 into an ethanol solution, adding the aqueous solution containing copper chloride to the ethanol solution containing porous titanium dioxide nanoparticles, ultrasonically dispersing uniformly to obtain a mixed solution, transferring the mixed solution to a hydrothermal reactor, and after high-temperature treatment, centrifuging the mixed solution, and washing with ethanol and water to obtain porous titanium dioxide nanoparticles doped with monovalent copper ions; Step 3: Preparation of monovalent copper ion-doped sonosensitizer: PVP is dispersed in water to obtain a solution containing PVP, and the porous titanium dioxide nanoparticles doped with monovalent copper ions obtained in step 2 are dispersed in the aqueous solution of PVP. After stirring overnight, the porous titanium dioxide nanoparticles doped with monovalent copper ions modified by PVP are obtained by centrifugation to obtain a monovalent copper ion-doped sonosensitizer.
3. The method for preparing the monovalent copper ion-doped sonosensitizer according to claim 2, characterized in that: The surfactant template solution is prepared by dispersing hexadecylamine in an ethanol solution.
4. The method for preparing the monovalent copper ion-doped sonosensitizer according to claim 2, characterized in that: The alkaline growth liquid is a mixture of ethanol and ammonia water.
5. The method for preparing the monovalent copper ion-doped sonosensitizer according to claim 2, characterized in that: The titanium dioxide precursor is isopropyl titanate.
6. The method for preparing the monovalent copper ion-doped sonosensitizer according to claim 2, characterized in that: The titanium dioxide precursor solution was added dropwise to the alkaline growth solution, and the mixed solution was stirred for 1.5 hours to grow titanium dioxide nanoparticles.
7. The method for preparing the monovalent copper ion-doped sonosensitizer according to claim 2, characterized in that: In the step 2, the titanium dioxide nanoparticles prepared in the step 1 are dispersed in an ethanol solution. In order to disperse the titanium dioxide nanoparticles in an ethanol solution of equal volume, a hydrothermal method is used to remove the surfactant hexadecylamine, and the doping and reduction of copper ions are simultaneously achieved; wherein the temperature of the hydrothermal method is 150-200° C., and the hydrothermal reaction time is 1-12 hours.
8. Use of the monovalent copper ion-doped sonosensitizer according to claim 1 in the preparation of anti-tumor drugs.
9. The use according to claim 8, characterized in that , the concentration range of the sonosensitizer is 0-80ug / mL.
10. The use according to claim 8, characterized in that ,Use ultrasound therapy device to ultrasonically treat the sonosensitizer.
